Webinar

Cardiometabolic research in the GLP-1 era

GLP-1 therapies are reshaping cardiometabolic care. What began as a diabetes treatment story now spans obesity, cardiovascular risk and long-term outcomes. As GLP-1 adoption accelerates, join HealthVerity to explore key research questions in the GLP-1 era and how richer real-world data can help answer them.

In this discussion we walk through the challenges researchers face today and demonstrate how linking claims, labs, EHR and clinical notes reveals a better patient journey.

What you'll learn:

• The key cardiometabolic research questions emerging in the GLP-1 era
• Why claims alone often miss critical clinical context such as BMI, A1c trends and treatment response
• How linked claims, labs, EHR and clinical notes enable deeper analysis of treatment pathways and outcomes